With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through our nearly 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|NUDT15 Polymorphisms and Individualization of Thiopurine Therapy in Children with Acute Lymphoblastic Leukemia||St. Jude Children's Research Hospital / Takaya Moriyama, MD/PhD||Young Investigator Grants||2018||Tennessee|
|Modeling GATA2 Associated MDS/AML Predisposition Syndrome Using Color-Barcoding and Mutagenesis in Zebrafish||Dana-Farber Cancer Institute / Serine Avagyan, PhD||Young Investigator Grants||2018||Massachusetts|
|Investigating the role of BAI1 in the Metastasis of Medulloblastoma||Emory University / Satoru Osuka, MD/PhD||Young Investigator Grants||2018||Georgia|
|Effect of SLCO Polymorphisms on High-Dose Methotrexate Clearance in Pediatric Oncology Patients||Vanderbilt University Medical Center / Rachael Schulte, MD||Young Investigator Grants||2018||Tennessee|
|Targeting the Metabolic Drivers of Chemo Resistance in Acute Myeloid Leukemia||Harvard University / Nick van Gastel, PhD||Young Investigator Grants||2018||Massachusetts|
|Augmenting Chimeric Antigen Receptor T Cell Induced Epitope Spreading for Pediatric Solid Tumors||Children's Hospital of Philadelphia / Michael Leibowitz, MD/PhD||Young Investigator Grants||2018||Pennsylvania|
|Divergent Core Transcriptional Regulatory Circuitries to Highlight Context-Specific Vulnerabilities in AML||Dana-Farber Cancer Institute / Maxim Pimkin, MD/PhD||Young Investigator Grants||2018||Massachusetts|
|MYC-driven Core Regulatory Circuits in Neuroblastoma||Dana-Farber Cancer Institute / Mark Zimmerman, PhD||Young Investigator Grants||2018||Massachusetts|
|Describing the Biological Impacts of Gain-of-function SAMD9 Mutations||St. Jude Children's Research Hospital / Jason Schwartz, MD/PhD||Young Investigator Grants||2018||Tennessee|
|Novel Antibodies to the C2-set Domain of CD33 for Acute Myeloid Leukemia Immunotherapy||Fred Hutchinson Cancer Research Center / Colin Godwin, MD||Young Investigator Grants||2018||Washington|